Chengdu Ucello Biotechnology Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Chengdu Ucello Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| CAR-T for Claudin18.2 Positive Solid Tumors (NCT07266311) | Chengdu Ucello Biotechnology Co., Ltd. | 2025-12-15 |
| Allogeneic UCB-derived CAR-T for SLE (NCT07274059) | Chengdu Ucello Biotechnology Co., Ltd. | 2025-03-26 |
Track Chengdu Ucello Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.